Displaying 1-10 of 10 result(s).
| Board Name | Posts By cindydonut | Post Created |
|---|---|---|
| GIFT RDE Inc. | Seems Bill has taken control of the  (1) | 05/16/2017 8:54:38 AM |
| GIFT RDE Inc. | Well that was a Debbie Downer post (1) | 04/27/2017 8:26:09 AM |
| GIFT RDE Inc. | Great Post Pork Chop! So many seem (2) | 04/25/2017 9:15:58 AM |
| GIFT RDE Inc. | Never bet against the Warrior. The (7) | 04/22/2017 11:34:24 AM |
| GIFT RDE Inc. | Love all the speculation. Fun Times (3) | 04/21/2017 2:34:55 PM |
| GIFT RDE Inc. | Seems Bill has been on a brutal sch (1) | 04/21/2017 8:25:31 AM |
| GIFT RDE Inc. | People need to remember, after Cana (6) | 04/19/2017 8:53:21 AM |
| GIFT RDE Inc. | Never been this excited about a Com (2) | 04/19/2017 7:08:07 AM |
| GIFT RDE Inc. | What a pathetic post that is. Such (1) | 04/18/2017 5:18:01 PM |
| GIFT RDE Inc. | This board looks like fun, think I (1) | 04/18/2017 3:27:16 PM |
Recent Articles
- Osisko Development Secures Major Funding for Cariboo Project
- Exploring Innovations in CNS Conditions at Axsome R&D Day
- BYD Faces Sales Decline as Electric Vehicle Competition Grows
- First American Uranium Inc. Outlines Share Consolidation Strategy
- Biogen's Commitment: $2 Billion Manufacturing Investment Unveiled
- BlackSky Technology Announces Q2 2025 Conference Call Details
- Innovative Kidney Care Partnership Enhances Patient Outcomes
- iTeos Therapeutics' Merger with Concentra: A New Chapter Ahead
- Compugen Begins Groundbreaking Trial for Ovarian Cancer Treatment
- Grown Rogue International Prepares for Q2 2025 Financial Insights
- Verizon's Q2 Performance: Rising Guidance and Market Expansion
- Roper Technologies' Q2 Results: Revenue Surge and Acquisition Insights
- Standard BioTools Inc. Announces Q2 Earnings Call Schedule
- 3D Systems Corporation Faces Potential Securities Fraud Lawsuit
- Explore Innovation in Health and Technology on Advancements
- Discover PDFgear Scan: Your New Free AI Scanner App
- Transforming Patient Care: hellocare.ai's New Integration
- Petco Securities Class Action: What Investors Need to Know
- Keel Farms Invites You to Celebrate Christmas in July
- Japan Elections Create Turmoil Amidst Ongoing Earnings Season
- Understanding Retail Speculation and Its Risks in Today's Market
- WEBUY Global's Innovative AI Device Sets New Travel Standards
- SmartPayNet Grows Global Reach with Enhanced Payment Services
- NodThera Welcomes Dr. Jyothis George as Chief Medical Officer
- Osisko Development Receives $450 Million Financing for Cariboo Project
- Fraud.net Expands Service Offerings Across Asia and the UAE
- Elevating Awareness: Tonix Pharmaceuticals' Campaign for Fibromyalgia
- XRP Hits New Heights with RI Mining's Eco-Friendly Cloud Solution
- Synthego Makes Strategic Move with Perceptive Advisors Acquisition
- Stellantis Faces Major Financial Challenges Amid Tariff Issues
- Rogers Communications Enhances Cash Tender Offers for Debt
- Exciting Collaboration: Ms. Rachel Joins Tonies for Kids
- Discover Easy Daily Earnings with ETHRANSACTION Mining
- Activating Innovation: Capital Investment Boosts XNRGY Growth
- Unlocking Daily Earnings with ETHRANSACTION's Mining Contracts
- Kraig Biocraft Laboratories Innovates Spider Silk Production Techniques
- Beneficient Expands Leadership with New Chairman and CEO
- Gilat Satellite Networks: A Leader in Satellite Connectivity
- Globe Life Inc. Highlights Upcoming Earnings Report
- Axsome Therapeutics Celebrates Milestone at Nasdaq with R&D Day
- Alan Lowe Appointed to Modine's Board of Directors
- NCCN Updates Guidelines for Monoclonal Antibodies in Cancer Care
- DIFI Consortium to Host 2025 Workshop at MILCOM Event
- AquaSonic Car Wash Launches Innovative Service Across U.S.
- BioCryst Pharmaceuticals Set to Share Q2 2025 Financials Soon
- Upcoming Financial Results Announcement from Cannara Biotech
- Signify Updates on Strategic Share Repurchase Program
- Youth Soccer Takes Center Stage at Cadiz Global Cup 2025
- Rogers Expands Cash Tender Offers for Multiple Debt Securities
- George Medicines Partners with Azurity for Innovative Treatment